Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029289 · ClinicalTrials.gov registry record · Phase 1
Effects of Lutein in Retinitis Pigmentosa
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00029289: Completed Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00029289 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029289, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
Interventions
- DRUG Lutein (10 or 30 mg/day) capsules
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-04 |
| Est. Completion | 2002-10 |
| Phase | Phase 1 |
What the finished NCT00029289 record still lists
NCT00029289 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Lutein (10 or 30 mg/day) capsules is the first listed.
NCT00029289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029289 about?
NCT00029289 is a clinical study titled "Effects of Lutein in Retinitis Pigmentosa". Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
What is the current status of trial NCT00029289?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-04. Estimated completion is 2002-10.
What interventions are being tested in trial NCT00029289?
The interventions under investigation include: Lutein (10 or 30 mg/day) capsules (DRUG).
Who is sponsoring clinical trial NCT00029289?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia